QS/1, RxTran partner on pharmacy translation
CAMBRIDGE, Mass. — QS/1 will offer its pharmacy clients prescription-translation software under a new partnership with pharmacy language service firm RxTran, the two companies said Thursday.
RxTran is delivered as a software-as-a-service application, allowing pharmacies to quickly and accurately provide written prescription translations to customers with limited English proficiency, thus providing them with a fuller understanding of medication directions and usage. According to the U.S. Census Bereau, the population of people with limited English proficiency grew by 80% between 1990 and 2010.
"QS/1 is committed to providing its pharmacy customers with the tools they need to offer the best patient care possible," QS/1 senior manager for marketing and analyst Michael Ziegler said. "Using RxTran allows pharmacies to translate prescription information into a patient’s native language."
RxTran provides translation services in Arabic, Bengali, French, German, Greek, Haitian Creole, Hindi, Italian, Korean, Portuguese, Russian, simplified and traditional Chinese character sets, Spanish, Tagalog and Vietnamese.
"We are excited and proud to partner with QS/1," RxTran CEO Brian Kratt said. "The integration of these technologies provides pharmacies with an affordable language solution that enables them to improve patient safety and provide better patient care to limited-English-proficiency customers."
Physician, talk show co-host Travis Stork appointed to telehealth provider’s advisory board
SUNRISE, Fla. — Telehealth services and software provider MDLive has appointed a nationally known physician and talk show co-host as chairman of its medical advisory board.
MDLive announced Wednesday the appointment of Travis Stork, who is co-host of the Emmy award-winning daytime talk show "The Doctors."
The company said Stork’s role would be one of a "true hands-on partnership" that would include taking calls from MDLive patients and helping the company design processes that ensure the highest standards of care and customer experience. He will work with MDLive’s nationwide network of physicians to help them offer the highest-quality care, the company said.
"MDLive is for everyone, and I’m delighted to be joining a company that is dedicated to offering immediate access to quality health care," Stork said. "With waiting times to see a doctor increasing, MDLive provides quick, convenient access to experienced, board-certified physicians."
The company’s physicians can diagnose, treat and write prescriptions for many drugs, with exception to controlled substances, for routine medical conditions all day and any day of the year.
"Our close partnership with Dr. Stork will capitalize on our joint vision for delivering an incredible customer experience never seen before in health care, providing superb, affordable care anytime, anywhere in a confidential and trustworthy manner," MDLive CEO Randy Parker said. "MDLive offers care on the patients’ terms, and our network of doctors can diagnose, treat and even prescribe medication when appropriate to help people avoid unnecessary hassles of traveling to the ER and dealing with the frustration of crowding waiting rooms. We look forward to working with Dr. Stork in bringing back the house call to create a new unprecedented standard of patient care."
Reports: New Maine law allows drug importation
NEW YORK — A new law in Maine will allow consumers to purchase drugs by mail order from some pharmacies overseas, according to published reports.
The Wall Street Journal reported Wednesday that the law, a first, had sparked lawsuits from drug companies, who say the law will threaten patient safety by opening the U.S. supply chain to counterfeit and adulterated medications. Supporters of the law, including Republican Gov. Paul LePage, say drug makers are more concerned about losing money from the law.
The law formalizes a practice that has existed in the state for several years. According to the Journal, the city of Portland, Maine, was able to save $3.2 million between 2004 and 2012 by going through the broker CanaRx.
Currently, the Food and Drug Administration prohibits importation of drugs, and the agency would not comment on the law when asked by Journal reporters. The newspaper noted that Americans pay more for drugs than people in countries where governments set price ceilings or negotiate prices with drug manufacturers.